Weisenburger D D, Astorino R N, Glassy F J, Miller C H, MacKenzie M R, Caggiano V
Cancer. 1985 Oct 15;56(8):2061-8. doi: 10.1002/1097-0142(19851015)56:8<2061::aid-cncr2820560829>3.0.co;2-2.
We analyzed the clinicopathologic features of 13 patients with immunologically confirmed peripheral T-cell lymphoma. The lymphomas were classified into poorly differentiated lymphocytic, mixed cell, and large cell types. Marked morphologic heterogeneity was noted within the mixed cell and large cell categories, and the various subtypes are described. Twelve of the 13 patients received multiagent chemotherapy. Only three of the nine patients with poorly differentiated or mixed cell lymphomas achieved a complete remission, and the median survival for this group was 11 months. In contrast, all three of the treated patients with large cell lymphomas achieved a complete remission, two of whom are alive without disease (14 and 29 months, respectively). Classification of peripheral T-cell lymphomas into lymphocytic, mixed cell, and large cell types, as well as further subclassification within the heterogeneous groups, is suggested so that pathologic features of prognostic significance can be identified.
我们分析了13例经免疫确诊的外周T细胞淋巴瘤患者的临床病理特征。这些淋巴瘤分为低分化淋巴细胞型、混合细胞型和大细胞型。在混合细胞型和大细胞型中观察到明显的形态学异质性,并描述了各种亚型。13例患者中有12例接受了多药化疗。9例低分化或混合细胞淋巴瘤患者中只有3例达到完全缓解,该组的中位生存期为11个月。相比之下,3例接受治疗的大细胞淋巴瘤患者均达到完全缓解,其中2例无病存活(分别为14个月和29个月)。建议将外周T细胞淋巴瘤分为淋巴细胞型、混合细胞型和大细胞型,以及在异质性组内进一步细分,以便识别具有预后意义的病理特征。